Earticle

Background: Indiscriminate use of antibiotics in livestock and poultry farming has caused emergence of new pathogenic strains. The situation has warrented the development of safe and alternative growth promoters and immunity enhancers in livestock. Herbal additives in animal and bird feed is a centuries-old practice. Thus, the present study investigated the efficacy of a standardized formulation of lipophilic turmeric extract containing curcumin and turmerones, (TF-36), as a natural growth promoter poultry feed additive. Methods: The study was designed on 180 one-day old chicks, assigned into three groups. Control group (T0) kept on basal diet and supplemented groups T0.5 and T1 fed with 0.5% and 1% TF-36 fortified basal diet for 42 days. Each dietary group consisted of six replicates of ten birds. Body weight, food intake, food conversion ratio, skin colour, blood biochemical analysis and antioxidant status of serum were investigated. Results: Body weight improved significantly in T1 with a 10% decrease in FCR as compared to the control. TF-36 supplementation in T1 enhanced the antioxidant enzyme activity significantly (p < 0.05) with a decrease (p < 0.05) in lipid peroxidation. It also caused a slight yellow skin pigmentation without any change in meat color, indicating the bioavailability of curcumin from TF-36. However, no significant change in the concentration of serum creatinine, total protein and liver enzyme activities were observed, indicating the safety. Conclusion: In summary, we concluded that TF-36 can be a natural feed additive to improve growth performance in poultry, probably due to the better antioxidant activity and antimicrobial effects contributed by the better bioavailability of curcuminoids and turmerones. Besides, curcuminoids and turmerones were also known to be gastroprotective and anti-inflammatory agents.

퇴행성 신경질환 치료를 위한 AChE inhibitor 관련 연구로써 생물학적 유용성을 높인 커큐민에 대한 연구를 수행하게 되었다. 본 연구의 목적은 아리큐민(강황추출물)에 대한 in vitro 신경보호 효과를 확인하는데 있다. 신경보 호효과를 확인하기 위해 아리큐민(강황추출물)에 대한 AChE inhibition을 평가하였고, HT-22 세포에 대한 세포생존 율을 분석하였으며, 산화스트레스(glutamate, H202) 유발에 따른 HT-22 세포생존을 확인하였다. 아리큐민(강황추출 물)의 AChE 저해율 변화결과 아리큐민 39.06㎍/㎖ 이상의 농도에서 약 20% 이상의 AChE 활성을 저해하는 것으로 확인하였다. 그리고 산화스트레스(glutamate 5 mM 및 H2O2 500 μM) 유발 HT-22 cell의 세포 독성을 0.01~0.1 mg/ml 농도에서부터 유의하게 억제하는 것을 확인하였다(p<0.05). 이와 같은 결과로 볼 때 아리큐민(강황추출물)은 신경보호 효과 효능이 우수한 것으로 확인되었다.

This study was conducted on curcumin which had increased bioavailability as a potential AChE inhibitor for the treatment of neurodegenerative diseases. The purpose of this study is to confirm the in vitro neuroprotective effect on Aricumin (turmeric extract). To confirm the neuroprotective effect, AChE inhibition for Aricumin was evaluated, and cell viability was analyzed for HT-22cell, and oxidative stress (glutamate, H2O2)-induced HT-22 cytotoxicity was evaluated. As a result of the change in the AChE inhibition rate of Aricumin (Turmeric extract), it was confirmed that Aricumin at a concentration of 39.06㎍/㎖ or higher inhibited AChE activity by about 20% and more. And it was confirmed that the cytotoxicity of HT-22 cells induced by oxidative stress (Gluamate 5 mM and H2O2 500 μM) was significantly inhibited from 0.01 to 0.1 mg/ml concentration (p<005). These results suggest that Aricumin (turmeric extract) have potential neuroprotective effects.

Effects of methanol extract from turmeric (Curcuma longa L.) (CME) on underlying mechanisms of lipolysis were investigated in 3T3-L1 adipocytes. Compared to the control, lipid accumulation with 72 hr treatment of CME at the concentration 20 μg/mL was significantly decreased by 19.9% as quantified by Oil red O dye. Intracellular triglyceride (TG) content was also lowered by 19.3%. To determine the mechanism for TG content reduction, glycerol release level was measured. Incubation of 3T3-L1 adipocytes with 15 and 20 μg/mL of CME significantly elevated the level of free glycerol released into the cultured medium by 20.4 and 28.6%, respectively. In subsequent measurements using quantitative real-time polymerase chain reaction (PCR), mRNA levels of hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) were significantly increased by 21.2 and 24.9%, respectively, at the concentration 20 μg/mL. Results indicated that CME stimulated lipolysis through induction of HSL and ATGL mRNA expressions, resulting in increased glycerol release.

Turmeric (Curcuma longa L.) has been used as a spice such as curries. Although its various biological functions including anti-allergenic, and anti-carcinogenic activities were investigated, the total phenolic content of water and ethanol turmeric extracts and correlation between phenolic content and biological functions including antioxidant and anti-adipogenic activities of turmeric are relatively unknown. Here, we prepared water and ethanol turmeric extracts (W-TE and E-TE). The total phenolic content of W-TE and E-TE were 1.64%, and 9.31%, respectively. To examine the antioxidant activities of W-TE and E-TE, DPPH assay was employed. The E-TE showed strong scavenging activity against DPPH radicals than that of W-TE. The MTT assay was employed to evaluate the cytotoxicity of E-TE on 3T3-L1 cells. The treatment of 10, 25, and 50 μg/ml E-TE for 24 h dose not affect to the 3T3-L1 cell viability. Therefore, the 10 and 50 μg/ml of E-TE were chose further experiment. We also found that the 3T3-L1 adipogenesis was dose-dependently and significantly inhibited by 10, and 50 μg/ml E-TE treatment. The 50 μg/ml of E-TE suppressed 3T3-L1 adipogenesis by 71.53% when compared to adipocytes control. Moreover, the markedly suppressed lipid droplets were observed in E-TE treated 3T3-L1 adipocytes. The evidences suggest that the E-TE has the potential as a functional ingredient in the development of functional foods and nutri-cosmetics on overweight and obesity.

Influence of gelatinase on basement membrane (BM) structure was investigated by using a skin equivalent (SE) model. The results showed that (1) gelatinase produced by cells degraded the BM and (2) the addition of matrix metalloproteinase-specific inhibitor to the SE medium accelerated the formation of BM structure, indicating that gelatinase is involved in BM impairment. The activity of gelatinase was also studied in healthy human facial skin tissues. The result of in situ zymography revealed gelatinase activity around the basal layer of the epidermis, where BM integrity was severely compromised. Therefore, this enzyme was suggested to be associated with BM decomposition in human facial skin. To assess the behavior of gelatinase in stratum corneum (SC) non-invasively, an immunological study was performed. Since positive immunostaining of pro-gelatinase B was observed in SC stripped from sun-exposed skin, whereas no positive staining detected in SC of non-irradiated skin, gelatinase in the epidermis could be non-invasively detected by measuring gelatinase in SC. Gelatinase in SC of healthy female volunteers was monitored using a special film that sensitively and conveniently detects gelatinase. Ninetr percent of SC from facial skin (l00 women, 40's-50's) was gelatinase-positive. On the other hand, SC from non-irradiated skin was negative. These results strongly suggest that (1) gelatinase is constantly produced in the facial epidermis of most middle-aged woman during their daily life, and (2) the enzyme might be involved in the aging-related degeneration of both BM and the matrix fibers of the upper layer of the dermis, acting as a very important aging factor. Strong inhibitory activity against gelatinase was found in turmeric extract and identified curcumin as the major ingredient. Topical application of cream containing turmeric extract significantly decreased the number of gelatinase-positive SC clusters in human facial skins. These results indicated that turmeric is an effective ingredient to prevent skin from photo aging by suppressing chlonically upregulated gelatinase activity by UV and to improve skin condition.

This study investigated the effects of Angelica keiskei Koidzumi and turmeric extract supplementation(ATE) on blood lipids, antioxidant and inflammatory markers in 35 hypercholesterolemic Korean adults with high blood cholesterol levels (serum total cholesterol$\geq200mg/d{\ell}$ or LDL-cholesterol$\geq130mg/d{\ell}$). They received ATE(n=21, 14 females and 7 males) or placebo(control group, n=14, 11 females and 3 males) for 4 weeks. There was no significant change in serum total cholesterol, LDL-cholesterol and HDL-cholesterol levels after ATE supplementation in the both groups. However, the LDLcholesterol: HDL-cholesterol ratio(LPH) was significantly decreased and both serum prostagrandin E2(PGE2) levels were significantly decreased in those receiving ATE. No significant changes were evident in interleukin(IL)-$1\beta$, IL-6, IL-8, 8-isoprostane, malondialehyde, total antioxidant capacity and oxidized-LDL. These results suggest that complex extract of Angelica keiske and turmeric has the potential to decrease cardiovascular risk by reducing LPH and inflammatory mediator $PGE_2$ in hypercholesterolemic adults.

본 연구 결과 울금 에탄올 추출물이 DMBA에 의해 유도한 유선 암화과정에서 종양의 발생률과 종양수를 감소시킴을 확인하였다. 이러한 종양세포의 증식 억제 효과는 울금의 암 예방 효과에 대한 기본 메커니즘 중 하나이다. 앞으로 효과적인 투여 경로 및 조직 특이성을 검토하기 위하여 더 많은 연구가 필요하다고 사료된다.

The purpose of this study was to examine the potential of turmeric (Curcuma longa L.) to inhibit 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in rats. Female Sprague Dawley rats were fed a control diet (NC and DC) or an ethanol extract of turmeric (DT) diet until the end of the experiment. The rats in the DC and DT groups were administered a single dose of DMBA (50 mg/Kg) by oral gavages at 50 days of age. The turmeric ethanol extracts decreased the incidence and multiplicity of DMBA-induced mammary tumor. The turmeric ethanol extract significantly decreased the tumor cell proliferation. The turmeric also significantly decreased the tumor grade based on the degree of the tubule formation. The results suggest that the ethanol extract of turmeric has an inhibitory effect against mammary carcinogenesis, and that such chemopreventive effect may be related to the inhibition of the initiation and the proliferation of tumor cells.